121 related articles for article (PubMed ID: 9583424)
1. Controlling confounding when studying large pharmacoepidemiologic databases: a case study of the two-stage sampling design.
Collet JP; Schaubel D; Hanley J; Sharpe C; Boivin JF
Epidemiology; 1998 May; 9(3):309-15. PubMed ID: 9583424
[TBL] [Abstract][Full Text] [Related]
2. Two-stage sampling for etiologic studies. Sample size and power.
Schaubel D; Hanley J; Collet JP; Bolvin JF; Sharpe C; Morrison HI; Mao Y
Am J Epidemiol; 1997 Sep; 146(5):450-8. PubMed ID: 9290505
[TBL] [Abstract][Full Text] [Related]
3. [Application of disease-risk score in pharmacoepidemiologic studies].
Zhao HY; Zhan SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):261-266. PubMed ID: 28231678
[TBL] [Abstract][Full Text] [Related]
4. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
Backenroth D; Chase H; Friedman C; Wei Y
PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
6. Methods in pharmacoepidemiology.
Sommet A; Pariente A
Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
[TBL] [Abstract][Full Text] [Related]
7. Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.
Yu M; Xie D; Wang X; Weiner MG; Tannen RL
Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():60-8. PubMed ID: 22552981
[TBL] [Abstract][Full Text] [Related]
8. Efficient sampling approaches to address confounding in database studies.
Hanley JA; Dendukuri N
Stat Methods Med Res; 2009 Feb; 18(1):81-105. PubMed ID: 18815164
[TBL] [Abstract][Full Text] [Related]
9. Sampling strategies in nested case-control studies.
Langholz B; Clayton D
Environ Health Perspect; 1994 Nov; 102 Suppl 8(Suppl 8):47-51. PubMed ID: 7851330
[TBL] [Abstract][Full Text] [Related]
10. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
[TBL] [Abstract][Full Text] [Related]
11. [Bias and confounding: pharmacoepidemiological study using administrative database].
Nojiri S
Yakugaku Zasshi; 2015; 135(6):793-808. PubMed ID: 26028416
[TBL] [Abstract][Full Text] [Related]
12. Estimating causal log-odds ratio using the case-control sample and its application in the pharmaco-epidemiology study.
Zhu A; Zeng D; Zhang P; Li L
Stat Methods Med Res; 2019 Jul; 28(7):2165-2178. PubMed ID: 29355073
[TBL] [Abstract][Full Text] [Related]
13. Confounding and control of confounding in nonexperimental studies of medications in patients with CKD.
Bradbury BD; Gilbertson DT; Brookhart MA; Kilpatrick RD
Adv Chronic Kidney Dis; 2012 Jan; 19(1):19-26. PubMed ID: 22364797
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.
Franklin JM; Schneeweiss S; Solomon DH
Am J Epidemiol; 2017 Mar; 185(6):474-478. PubMed ID: 28399570
[TBL] [Abstract][Full Text] [Related]
15. Matching, an appealing method to avoid confounding?
de Graaf MA; Jager KJ; Zoccali C; Dekker FW
Nephron Clin Pract; 2011; 118(4):c315-8. PubMed ID: 21293153
[TBL] [Abstract][Full Text] [Related]
16. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
[TBL] [Abstract][Full Text] [Related]
17. Adjusted odds ratios for case-control studies with missing confounder data in controls.
Suissa S; Edwardes MD
Epidemiology; 1997 May; 8(3):275-80. PubMed ID: 9115022
[TBL] [Abstract][Full Text] [Related]
18. Two-stage case-control studies: precision of parameter estimates and considerations in selecting sample size.
Hanley JA; Csizmadi I; Collet JP
Am J Epidemiol; 2005 Dec; 162(12):1225-34. PubMed ID: 16269581
[TBL] [Abstract][Full Text] [Related]
19. The importance of pharmacoepidemiology in pregnancy-implications for safety.
Benevent J; Montastruc F; Damase-Michel C
Expert Opin Drug Saf; 2017 Oct; 16(10):1181-1190. PubMed ID: 28777918
[TBL] [Abstract][Full Text] [Related]
20. Multiple self-controlled case series for large-scale longitudinal observational databases.
Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
